Carlos Solano

41PUBLICATIONS
156CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Sep 17, 2026
GVHD prophylaxis and incidence in contemporary alloHSCT: a large real-world GETH/TC analysis.

|Sep 15, 2026
Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy.

|Jul 17, 2026
Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC).

|Jun 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL).

|Jan 26, 2026
Microbiome-Based Modeling of CAR-T Therapy Response in Lymphoma: Insights From Shotgun Metagenomics Sequencing.

Rafael Hernani, Eliseo Albert, Carlos Hernani-Morales

|Jan 13, 2026
Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study.

Marta Peña, Giulia Losi, Víctor Navarro

Pageof 7

Frequent Collaborators

16 joint publications

Dixie Huntley

13 joint publications

José Luis Piñana

12 joint publications

Juan Carlos Hernández-Boluda

8 joint publications

Jaime Sanz